Afatinib Dimaleate 30 Mg Australia

Afatinib Dimaleate 30 mg is an oral targeted therapy used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by blocking EGFR proteins that help cancer cells grow and spread, slowing disease progression. It is usually taken once daily on an empty stomach, at the same time each day. Common side effects include diarrhea, skin rash, mouth sores, and nail changes. Active Ingredient (Generic Name): Afatinib Dimaleate Indication: Non-small cell lung cancer Manufacturer: Boehringer Ingelheim India Pvt.Ltd Packaging: 7 tablets in 1 strip Strength 30mg Delivery Time: 6 To 15 days